{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:11:44Z","timestamp":1792120304436,"version":"4.4.0"},"reference-count":38,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T00:00:00Z","timestamp":1106697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In an attempt to find new types of anti\u2010sickling agents that specifically bind to intracellular sickle haemoglobin (HbS) without inhibition by plasma and tissue proteins or other undesirable consequences, we identified 5\u2010hydroxymethyl\u20102\u2010furfural (5HMF), a naturally occurring aromatic aldehyde, as an agent that fulfils this criterion. Preliminary studies <jats:italic>in vitro<\/jats:italic> showed that 5HMF forms a high\u2010affinity Schiff\u2010base adduct with HbS and inhibits red cell sickling by allosterically shifting oxygen equilibrium curves towards the left. Further studies with transgenic (Tg) sickle mice showed that orally administered 5HMF was rapidly absorbed into the bloodstream from the gastrointestinal tract without being destroyed, traversed the red blood cell membrane and specifically bound with, and modified, HbS molecules at levels as high as 90%. Pretreatment of Tg sickle mice with 5HMF inhibited the formation of sickle cells and significantly prolonged survival time under severe hypoxia, compared with untreated mice, which died within 15\u2003min because of sickling\u2010dependent pulmonary sequestration. These results indicate the feasibility of 5HMF as an attractive potential candidate for therapy of sickle cell disease.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05332.x","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T14:10:06Z","timestamp":1107267006000},"page":"552-561","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["5\u2010hydroxymethyl\u20102\u2010furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>\u2020,\u2021<\/sup>"],"prefix":"10.1111","volume":"128","author":[{"given":"Osheiza","family":"Abdulmalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.","family":"Safo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiukan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Brugnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaku","family":"Ohene\u2010Frempong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,2]]},"reference":[{"key":"e_1_2_22_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.6.1334.1334"},{"key":"e_1_2_22_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6215(90)84096-D"},{"key":"e_1_2_22_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-197909000-00008"},{"key":"e_1_2_22_5_1","first-page":"987","article-title":"Relationship between morphologic characteristics of sickle cells and method of deoxygenation","volume":"104","author":"Asakura T.","year":"1984","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_22_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.5.1594"},{"key":"e_1_2_22_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108681"},{"key":"e_1_2_22_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12589"},{"key":"e_1_2_22_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1984.tb10775.x"},{"key":"e_1_2_22_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1451"},{"key":"e_1_2_22_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(68)90430-0"},{"key":"e_1_2_22_12_1","volume-title":"Hemoglobin: Molecular, Genetic and Clinical Aspects","author":"Bunn H.F.","year":"1986"},{"key":"e_1_2_22_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.20.9259"},{"key":"e_1_2_22_14_1","volume-title":"Sickle Cell Disease: Basic Principles and Clinical Practice","author":"Embury S.H.","year":"1994"},{"key":"e_1_2_22_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02672.x"},{"key":"e_1_2_22_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1983.tb02137.x"},{"key":"e_1_2_22_17_1","first-page":"74","article-title":"Hydroxyurea and erythropoietin therapy in sickle cell anemia","volume":"19","author":"Goldberg M.A.","year":"1992","journal-title":"Seminars in Oncology"},{"key":"e_1_2_22_18_1","first-page":"60","article-title":"Morphology of sickle cells produced in solutions of varying osmolarities","volume":"117","author":"Hijiya N.","year":"1991","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_22_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00872a002"},{"key":"e_1_2_22_20_1","first-page":"613","article-title":"Morphologic studies of sickle erythrocytes by image analysis","volume":"115","author":"Horiuchi K.","year":"1990","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"e_1_2_22_21_1","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources Commission on Life Sciences","year":"1996"},{"key":"e_1_2_22_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03593.x"},{"key":"e_1_2_22_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04536.x"},{"key":"e_1_2_22_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-6915(00)00070-3"},{"key":"e_1_2_22_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90941-4"},{"key":"e_1_2_22_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/239217a0"},{"key":"e_1_2_22_27_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2390387"},{"key":"e_1_2_22_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_22_29_1","first-page":"501","article-title":"Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin","volume":"22","author":"Reilly M.P.","year":"1994","journal-title":"Experimental Hematology"},{"key":"e_1_2_22_30_1","first-page":"42","article-title":"Hydroxyurea therapy for diverse pediatric populations with sickle cell disease","volume":"34","author":"Rogers Z.R.","year":"1997","journal-title":"Seminars in Hematology"},{"key":"e_1_2_22_31_1","first-page":"585","article-title":"Introduction and expression of the human Bs\u2010globin gene in transgenic mice","volume":"42","author":"Rubin E.M.","year":"1988","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_22_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5339.873"},{"key":"e_1_2_22_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0498001"},{"key":"e_1_2_22_34_1","first-page":"489","volume-title":"Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management","author":"Steinberg M.H.","year":"2001"},{"key":"e_1_2_22_35_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.123.2.341"},{"key":"e_1_2_22_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04836.x"},{"key":"e_1_2_22_37_1","doi-asserted-by":"publisher","DOI":"10.1021\/jf00017a016"},{"key":"e_1_2_22_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)75254-5"},{"key":"e_1_2_22_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04892.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05332.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05332.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:21:32Z","timestamp":1697422892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05332.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05332.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05332.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2005-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}